Edmond de Rothschild Holding’s Editas Medicine EDIT Stock Holding History

Edmond de Rothschild Holding’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,500	Closed	-$50K	–	756
2018 Q1	$50K	Hold	1,500	–	–	﹤0.01%	618
2017 Q4	$46K	Hold	1,500	–	–	﹤0.01%	643
2017 Q3	$36K	Hold	1,500	–	–	﹤0.01%	688
2017 Q2	$25K	Hold	1,500	–	–	﹤0.01%	716
2017 Q1	$33K	Buy	+1,500	New	+$31.1K	﹤0.01%	693

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Edmond de Rothschild Holding's EDIT Position: Q2 2018 in Review

Edmond de Rothschild Holding sold out of Editas Medicine (EDIT) in Q2 2018, closing a stake of 1,500 shares — an estimated $50K sold.

Edmond de Rothschild Holding first reported a position in EDIT in Q1 2017 and held it in 5 quarters. The position peaked at $50K in Q1 2018. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2018.

Edmond de Rothschild Holding reported no remaining Editas Medicine position as of Q2 2018 after selling out during the quarter.
Edmond de Rothschild Holding sold 1,500 Editas Medicine shares in Q2 2018, an estimated $50K.
Edmond de Rothschild Holding first reported a position in Editas Medicine in Q1 2017 and held it in 5 quarters.
Edmond de Rothschild Holding's Editas Medicine position peaked at $50K in Q1 2018.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2018, filed 14 Aug 2018.